51 related articles for article (PubMed ID: 9121773)
1. Mutation analysis of the coding sequences of MEK-1 and MEK-2 genes in human lung cancer cell lines.
Bansal A; Ramirez RD; Minna JD
Oncogene; 1997 Mar; 14(10):1231-4. PubMed ID: 9121773
[TBL] [Abstract][Full Text] [Related]
2. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
Teng DH; Perry WL; Hogan JK; Baumgard M; Bell R; Berry S; Davis T; Frank D; Frye C; Hattier T; Hu R; Jammulapati S; Janecki T; Leavitt A; Mitchell JT; Pero R; Sexton D; Schroeder M; Su PH; Swedlund B; Kyriakis JM; Avruch J; Bartel P; Wong AK; Tavtigian SV
Cancer Res; 1997 Oct; 57(19):4177-82. PubMed ID: 9331070
[TBL] [Abstract][Full Text] [Related]
3. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
4. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
Fujishita T; Mizushima Y; Kashii T; Kobayashi M
Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
[TBL] [Abstract][Full Text] [Related]
5. Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system.
Papin C; Denouel A; Calothy G; Eychène A
Oncogene; 1996 May; 12(10):2213-21. PubMed ID: 8668348
[TBL] [Abstract][Full Text] [Related]
6. A temperature-sensitive MEK mutation demonstrates the conservation of the signaling pathways activated by receptor tyrosine kinases.
Hsu JC; Perrimon N
Genes Dev; 1994 Sep; 8(18):2176-87. PubMed ID: 7958887
[TBL] [Abstract][Full Text] [Related]
7. Age-related reductions in the activation of mitogen-activated protein kinases p44mapk/ERK1 and p42mapk/ERK2 in human T cells stimulated via ligation of the T cell receptor complex.
Whisler RL; Newhouse YG; Bagenstose SE
Cell Immunol; 1996 Mar; 168(2):201-10. PubMed ID: 8640866
[TBL] [Abstract][Full Text] [Related]
8. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells.
Plattner R; Gupta S; Khosravi-Far R; Sato KY; Perucho M; Der CJ; Stanbridge EJ
Oncogene; 1999 Mar; 18(10):1807-17. PubMed ID: 10086335
[TBL] [Abstract][Full Text] [Related]
9. The S387Y mutations of the transforming growth factor-beta receptor type I gene is uncommon in metastases of breast cancer and other common types of adenocarcinoma.
Anbazhagan R; Bornman DM; Johnston JC; Westra WH; Gabrielson E
Cancer Res; 1999 Jul; 59(14):3363-4. PubMed ID: 10416594
[TBL] [Abstract][Full Text] [Related]
10. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
Guha S; Lunn JA; Santiskulvong C; Rozengurt E
Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the Mek-MAP kinase-Rsk pathway in human breast cancer.
Salh B; Marotta A; Matthewson C; Ahluwalia M; Flint J; Owen D; Pelech S
Anticancer Res; 1999; 19(1B):731-40. PubMed ID: 10216485
[TBL] [Abstract][Full Text] [Related]
12. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells.
Whitehurst CE; Geppert TD
J Immunol; 1996 Feb; 156(3):1020-9. PubMed ID: 8557975
[TBL] [Abstract][Full Text] [Related]
13. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
14. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase.
Salmeron A; Ahmad TB; Carlile GW; Pappin D; Narsimhan RP; Ley SC
EMBO J; 1996 Feb; 15(4):817-26. PubMed ID: 8631303
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.
Sunahara M; Shishikura T; Takahashi M; Todo S; Yamamoto N; Kimura H; Kato S; Ishioka C; Ikawa S; Ikawa Y; Nakagawara A
Oncogene; 1999 Jun; 18(25):3761-5. PubMed ID: 10391684
[TBL] [Abstract][Full Text] [Related]
17. Absence of activating mutations of the RAF1 protooncogene in human lung cancer.
Miwa W; Yasuda J; Yashima K; Makino R; Sekiya T
Biol Chem Hoppe Seyler; 1994 Oct; 375(10):705-9. PubMed ID: 7888083
[TBL] [Abstract][Full Text] [Related]
18. Involvement of extracellular signal-regulated kinase module in HIV-mediated CD4 signals controlling activation of nuclear factor-kappa B and AP-1 transcription factors.
Briant L; Robert-Hebmann V; Sivan V; Brunet A; Pouysségur J; Devaux C
J Immunol; 1998 Feb; 160(4):1875-85. PubMed ID: 9469449
[TBL] [Abstract][Full Text] [Related]
19. Ligation of the T cell receptor complex results in activation of the Ras/Raf-1/MEK/MAPK cascade in human T lymphocytes.
Franklin RA; Tordai A; Patel H; Gardner AM; Johnson GL; Gelfand EW
J Clin Invest; 1994 May; 93(5):2134-40. PubMed ID: 8182145
[TBL] [Abstract][Full Text] [Related]
20. No mutations of the Bub1 gene in human gastric and oral cancer cell lines.
Nakagawa H; Yokozaki H; Oue N; Sugiyama M; Ishikawa T; Tahara E; Yasui W
Oncol Rep; 2002; 9(6):1229-32. PubMed ID: 12375025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]